Aveanna Healthcare Holdings, Inc. (AVAH) · Aug 13, 2026 · Earnings

The real surprise is not growth—it’s the size of the guidance lift

Beat — Diluted EPS $0.18 vs ~$0.17 consensus; FY Adjusted EBITDA raised to >$365M from $338M–$342M

Aveanna topped quarterly expectations and raised 2026 targets well above its prior range, though margin pressure remains visible beneath the growth.

The quarter cleared the market’s bar. Revenue reached $670.5 million versus a published consensus of roughly $650.4 million, while diluted EPS was $0.18 versus approximately $0.17 expected. Adjusted EPS was higher at $0.22, up from $0.18 a year earlier. That makes this more than a routine in-line report. (Financial Highlights; Income Statement)

MetricQ2 2026Q2 2025Change / expectation
Revenue$670.5M$589.6M+13.7%; roughly $650.4M consensus
Net income$40.3M$27.0M+49.1%
Diluted EPS$0.18$0.13Versus roughly $0.17 consensus
Adjusted diluted EPS$0.22$0.18+22.2%
Adjusted EBITDA$95.4M$88.4M+8.0%
Gross margin32.6%35.8%Down 3.2 percentage points
Field contribution margin18.1%20.5%Down 2.4 percentage points

The bigger signal is the unusually large guidance upgrade. Full-year revenue guidance moved from $2.63–$2.65 billion to above $2.68 billion, while Adjusted EBITDA guidance rose from $338–$342 million to above $365 million. The EBITDA midpoint increased by at least roughly 7%, a stronger upgrade than the revenue change and the clearest evidence that management sees the first-half performance as durable rather than a one-quarter event. (Full Year 2026 Guidance)

Growth is still being purchased with lower field profitability. Revenue expanded across all three divisions, led by Private Duty Services, but Q2 gross margin fell to 32.6% from 35.8%. PDS revenue rose 14.0%, yet its spread rate declined 11.1% to $12.88 per hour; field contribution margin also contracted to 18.1% from 20.5%. This does not overturn the beat, but it limits how clean the operating improvement is. (Segment Results — PDS; Key Performance Measures)

The net read is clearly above expectations, with leverage still the watchpoint. Six-month operating cash flow was $85.3 million and free cash flow was $75.4 million, while total debt stood at $1.48 billion against $97.2 million of cash. Lower interest expense helped earnings, and the company has substantial revolver capacity, but the balance sheet remains heavily indebted. Overall, the earnings beat and materially higher EBITDA outlook outweigh the margin compression, making this a genuine Beat rather than merely a favorable presentation. (Cash Flow and Information about Indebtedness; Liquidity, Cash Flow, and Debt)

What to watch next

Q3 earnings report, likely November

Original filing on SEC EDGAR

More Aveanna Healthcare Holdings, Inc. news

The real surprise is not growth—it’s the size of the guidance lift | AVAH Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.